A- A A+

Commune Health Workers' Methadone Maintenance Treatment (MMT) Knowledge and Perceived Difficulties Providing Decentralized MMT Services in Vietnam.

Lin C, Tuan NA, Li L.

Subst Use Misuse. 2018 Jan 28;53(2):194-199. doi: 10.1080/10826084.2017.1310248.


Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis.

Blum K, Modestino EJ, Neary J, Gondré-Lewis MC, Siwicki D, Moran M, Hauser M, Braverman ER, Baron D, Steinberg B, Laughlin TM, Badgaiyan RD.

Biomed J Sci Tech Res. 2018 Jan 7;2(2):1-4. doi: 10.26717/BJSTR.2018.02.000738.


USA. ER staffers under assault. Blame the opioid crisis.

 (HealthDay)—Emergency departments are becoming increasingly violent places as doctors bear the brunt of fallout from the opioid epidemic, a new survey shows. (MedicalXpress, USA, 02.10.2018)


USA. As Opioid Crisis Deepens, The Methadone Business Is Booming

The nation’s hardest hit communities are turning to the long-stigmatized opioid treatment. (Huffington Post, USA, 01.11.2018)


MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study.

Schuman-Olivier Z, Borodovsky JT, Steinkamp J, Munir Q, Butler K, Greene MA, Goldblatt J, Xie HY, Marsch LA.

Addict Sci Clin Pract. 2018 Sep 24;13(1):21. doi: 10.1186/s13722-018-0122-4.


USA. New opioid treatment resources for emergency department clinicians

The National Institute on Drug Abuse (NIDA) today announced the availability of informational resources for clinicians interested in initiating buprenorphine treatment in emergency department settings. (NIDA, 03.10.2018)


Schweiz. 313 Drogenabhängige werden durch Apotheken mit Methadon versorgt: Suchtberatung sucht Annäherung

Hausärzte, Apotheker, Psychiater, Psychologen und Suchtberater aus dem Sarganserland, Werdenberg und Liechtenstein sind bereit, bei Suchtpatienten zusammenzuarbeiten. (Tagblatt, Schweiz, 27.09.2018)


Irland. 20 years of the Methadone Treatment Protocol in Ireland

Delargy, Ide; Doran, Gillian; Patton, Patricia (eds) 

Irish College General Practitioners (ICGP)2018 

This is an overview of the ICGP Substance Misuse Programme as it has developed with particular reference to the 20 years of the Methadone Treatment Protocol which came into effect October 1998.


High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.

Socías ME, Wood E, Lake S, Nolan S, Fairbairn N, Hayashi K, Shulha HP, Liu S, Kerr T, Milloy MJ.

Addiction. 2018 Sep 20. doi: 10.1111/add.14398.



Die Behandlung von Opiatabhängigen in Zentralasien 

In den Ländern Zentralasiens – Kasachstan, Kirgisische Republik, Tadschikistan, Turkmenistan und Usbekistan – ist die Zahl der Opiatkonsumenten seit Anfang der 1990er Jahre immens gewachsen. Der Handel mit Opiaten ist stark ausgeprägt. Um diesen Problemen zu begegnen, unterstützt die Europäische Kommission die fünf Länder seit einigen Jahren durch das Zentralasien-Drogenaktionsprogramm (Central Asia Drug Action Programme, CADAP). Ziel des Programmes ist es, die negativen Folgen des Drogenkonsums zu lindern und die Einführung effektiver psychosozialer Behandlungsmethoden für Drogenabhängige einschließlich einer Substitutionsbehandlung zu fördern. Ingo Ilja Michelsund Co-Autor/innen berichten, welche Maßnahmen im Rahmen des Programmes durchgeführt werden und welche Ergebnisse schon vorliegen. (Konturen, 30.10.2018)


USA. Emergency Department Responses to Addiction - A Critical Intervention Point  (Video)

A hospital’s Emergency Department is often the only place a patient with substance use disorder receives healthcare. In some instances, this will be for an overdose, and in other cases it may be for an injury or infection related to their substance use. This makes the hospital a critical intervention point for engaging people with substance use disorders and linking them to treatment. (Addiction Policy Forum, USA, 25.09.2018, Video, 19:44)


Three-year retention in methadone opioid agonist treatment: A survival analysis of clients by dose, area deprivation, and availability of alcohol and cannabis outlets.

Amiri S, Hirchak K, Lutz R, McDonell MG, McPherson SM, Roll JM, Amram O.

Drug Alcohol Depend. 2018 Oct 6;193:63-68. doi: 10.1016/j.drugalcdep.2018.08.024.


Wissenschaft/Mensch: Drogenabhängige befolgen häufiger eine Opioid-Ersatztherapie, wenn sie Cannabis konsumieren

In einer großen Studie mit 820 Menschen, die illegale Drogen konsumierten und sich einer Opioidagonist-Therapie unterzogen, war die Befolgung der Behandlung besser, wenn sie gleichzeitig mindestens täglich Cannabis konsumierten. Wissenschaftler des Zentrums für Substanzkonsum von British Columbia in Vancouver (Kanada) veröffentlichten ihre Ergebnisse in der Zeitschrift Addiction. Die Teilnehmer begannen ihre Behandlung mit Methadon oder Buprenorphin/Naloxon zwischen September 1996 und Mai 2016. Der wichtigste Zielparameter war die Beibehaltung der Behandlung, definiert als Beibehaltung der Behandlung (auf der Basis von Methadon oder Buprenorphin/Naloxon) für zwei aufeinanderfolgende 6-monatige Beobachtungszeiträume.

Mindestens täglicher Cannabiskonsum zusätzlich zu Methadon oder Buprenorphin war im Vergleich zu Nichtkonsumenten von Cannabis oder weniger Konsumierenden positiv mit einer Beibehaltung der Behandlung assoziiert. Die Autoren folgerten, dass bei „Menschen in Vancouver, die illegale Drogen konsumieren und mit einer Opioidagonist-Behandlung beginnen, mindestens täglicher Cannabiskonsum mit einer etwa 21 % größeren Wahrscheinlichkeit für die Beibehaltung der Therapie verglichen mit weniger als täglichen Konsum verbunden ist“. (IACM-Informationen vom 29. September 2018)


UK. "How do we retain OST patients in treatment?"

In a recent Clinical Update editor Tom Jones summarises and comments on a primary care cohort study in the United Kingdom - a study that considers whether the use of methadone or buprenorphine as opioid substitution treatment (OST) was associated with a greater reduction in the risk of all-cause mortality and opioid drug-related poisoning mortality. In commenting on the paper, he considers the wider question - how do we retain patients on OST in treatment? (SMMGP - Großbritannien. Substance Misuse Management in General Practice, UK, 18.10.2018)

The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom.

Hickman M., Steer C., Tilling K., Lim A. G., Marsden J., Millar T., Strang J., Telfer M., Vickerman P. & Macleod J. (2018) Addiction, 113(8): 1461-1476. doi: 10.1111/add.14188.


USA. The HEALing Communities Study: Using Science to Address the Opioid Crisis

By Nora D. Volkow, MD and Francis S. Collins, M.D., Ph.D., NIDA, Nora’s Blog, 19.09.2018

The public health emergency of opioid misuse, addiction, and overdose affects millions of Americans and requires innovative scientific solutions. Today, during “National Prescription Opioid and Heroin Awareness Week,” we are sharing news of an important step towards these solutions through the HEALing Communities Study – an integrated approach to test an array of interventions for opioid misuse and addiction in communities hard hit by the opioid crisis. 


USA. “It Just Starts All Over Again” - inside a methadone clinic (Video)

“It Just Starts All Over Again,” an original Filter video by Helen Redmond, takes us inside a methadone clinic—and the problems with the system. (Filter, USA, 24.09.2018, Video, 05:26)


One size does not fit all – evolution of opioid agonist treatments in a naturalistic setting over 23 years.

Nordt, C., Vogel, M., Dey, M., Moldovanyi, A., Beck, T., Berthel, T., Walter, M., Seifritz, E., Dürsteler, K. M., and Herdener, M. (2018) 

Addiction, doi.org/10.1111/add.14442.



USA. Black Market For Suboxone Gives Some A Glimpse Of Recovery

(...) Some leading addiction experts argue that self-treatment with buprenorphine can save lives because it is used in place of more dangerous substances that are blamed for the continued rise in overdose deaths.

“It was not diverted buprenorphine that’s responsible for our current situation,” said Dr. Zev Schuman-Olivieran addiction specialist and instructor at Harvard Medical School. “The majority of people are using it in a way that reduces their risk of overdose.” (Kaiser Health News, USA, 09.10.2018)


Best Practices across the Continuum of Care for Treatment of Opioid Use Disorder.

Taha, S. (2018)

Ottawa, Ont.: Canadian Centre on Substance Use and Addiction. 


USA. Addiction Treatment Gap Is Driving A Black Market For Suboxone

(...) addiction treatment professionals argue the problem of buprenorphine diversion is often misunderstood. A black market exists in part, they point out, because addiction treatment can be hard to find. President Trump is expected to sign a bill that would increase access to the medication, but it's unclear how quickly that access will grow.

In the meantime, many people suffering from addiction will turn to the black market to try to treat addiction on their own. (...)

Dr. Kelly Clark, president of the American Society of Addiction Medicine, which supports the measure that would increase access to buprenorphine, believes making the drug more widely available outweighs the risk. For one thing, buprenorphine is not as dangerous as other opioids. "The risks of overdose with buprenorphine are minimal," she says. (NPR – National Public Radio, USA, 05.10.2018)


National trends and characteristics of inpatient detoxification for drug use disorders in the United States.

Zhu H, Wu LT.

BMC Public Health. 2018 Aug 29;18(1):1073. doi: 10.1186/s12889-018-5982-8.


Methadone maintenance treatment among patients exposed to illicit fentanyl in Rhode Island: Safety, dose, retention, and relapse at 6 months.

Stone AC, Carroll JJ, Rich JD, Green TC.

Drug Alcohol Depend. 2018 Aug 25;192:94-97. doi: 10.1016/j.drugalcdep.2018.07.019.



USA. Trapped by the ‘Walmart of Heroin’ (Feature)

A Philadelphia neighborhood is the largest open-air narcotics market for heroin on the East Coast. Addicts come from all over, and many never leave. (New York Times, 10.10.2018)


Integrating Responses at the Intersection of Opioid Use Disorder and Infectious Disease Epidemics: Proceedings of a Workshop.

National Academies of Sciences, Engineering, and Medicine. 2018. 

Washington, DC: The National Academies Press. doi.org/10.17226/25153.


USA. Study: Lack of Nearby OTPs Puts Methadone Patients at  Risk of Early Death

Under federal law, newly enrolled methadone patients must attend a methadone program six days a week, so caregivers can watch as patients are dosed.

But here’s the problem: Because many new methadone patients don’t have an opioid treatment program (OTP) nearby, this need for daily attendance markedly affects adherence. In fact, 20% to 50% of patients report poor or partial adherence during the most critical time of treatment—the first month, when patients face the highest risk of death.

That’s the subject of a study published this month in Journal of Substance Abuse Treatment. (at-forum, USA, 03.10.2018)


Chronic Pain Opioid-Maintained Patients Receive Less Analgesic Opioid Prescriptions.

Delorme J, Chenaf C, Bertin C, Riquelme M, Eschalier A, Ardid D, Authier N.

Front Psychiatry. 2018 Jul 23;9:335. doi: 10.3389/fpsyt.2018.00335. 


Improving outcomes in the treatment of opioid dependence (IOTOD): reflections on the impact of a medical education initiative on healthcare professionals' attitudes and clinical practice.

Webster S, Robinson S, Ali R, Marsden J.

J Eur CME. 2018 Sep 4;7(1):1506197. doi: 10.1080/21614083.2018.1506197.